Sort by
Refine Your Search
-
to realize their full potential. We actively support this by providing all of our full-time staff employees with at least 80 hours (10 days) of paid time per year to engage in professional development
-
by providing all of our full-time staff employees with at least 80 hours (10 days) of paid time per year to engage in professional development activities. Find out more about how you can grow your
-
their full potential. We actively support this by providing all of our full-time staff employees with at least 80 hours (10 days) of paid time per year to engage in professional development activities. Find
-
by providing all of our full-time staff employees with at least 80 hours (10 days) of paid time per year to engage in professional development activities. Find out more about how you can grow your
-
patient care. About the Center: The Center for Hematopoiesis and Hemoglobinopathies Research will focus on developing innovative therapies for sickle cell disease, thalassemia, and other inherited disorders
-
professional development activities. Find out more about how you can grow your career at UC Berkeley. Departmental Overview UC Berkeley's Haas School of Business offers a unique opportunity to champion new
-
to realize their full potential. We actively support this by providing all of our full-time staff employees with at least 80 hours (10 days) of paid time per year to engage in professional development
-
, Associate, or Full Specialist. The primary research area will focus on applying advanced MRI methods and/or machine learning to evaluate patients with brain tumors. The candidate will be expected to develop
-
are interested in identifying genes and proteins that regulate macrophage-mediated clearance of cancer cells. We are also interested in developing innovative CRISPR-based screening approaches to enable exploration
-
practicing physician-scientist runs the lab, focusing on understanding how tumors evolve in different therapeutic environments. The lab uses clinically relevant immunocompetent cancer models to develop & test